1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Perez, J.M.J. Siegal, G. Kriek, J. Hard, K. Dijk, J. Canters, G.W. Moller, W. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking UK Structure Fold.Des. FODEFH 1263 0969-2126 7 217 226 10.1016/S0969-2126(99)80027-6 10368288 The solution structure of the guanine nucleotide exchange domain of human elongation factor 1beta reveals a striking resemblance to that of EF-Ts from Escherichia coli. 1999 NE J.Biomol.NMR JBNME9 0800 0925-2738 12 467 1H, 15N and 13C Chemical Shift Assignment of the Guanine Nucleotide Exchange Domain of Human Elongation Factor-One Beta 1998 10.2210/pdb1b64/pdb pdb_00001b64 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 10148.631 ELONGATION FACTOR 1-BETA GUANINE EXCHANGE FACTOR DOMAIN 1 man polymer no no MLVAKSSILLDVKPWDDETDMAKLEECVRSIQADGLVWGSSKLVPVGYGIKKLQIQCVVEDDKVGTDMLEEQITAFEDYV QSMDVAAFNKI MLVAKSSILLDVKPWDDETDMAKLEECVRSIQADGLVWGSSKLVPVGYGIKKLQIQCVVEDDKVGTDMLEEQITAFEDYV QSMDVAAFNKI A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo Escherichia Escherichia coli sample BL21 9606 Homo sapiens 469008 Escherichia coli BL21(DE3) BL21 (DE3) PLASMID PET11A database_2 pdbx_database_status pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Database references Derived calculations Other 1 0 1999-05-18 1 1 2008-03-24 1 2 2011-07-13 1 3 2022-02-16 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.process_site Y BNL 1999-01-20 REL REL THE STRUCTURE WAS DETERMINED USING TRIPLE-RESONANCE NMR SPECTROSCOPY OF 13C, 15N-LABELED EF-1BETA. LEAST RESTRAINT VIOLATION 50 20 VARIOUS 100 mM 6.9 1 atm 303 K REFINEMENT DETAILS CAN BE FOUND IN THE JRNL CITATION ABOVE. simulated annealing 95% H2O AND 5% D2O GUNTERT,WUTHRICH refinement DYANA 1.4 structure solution DYANA V.1.4 V.1.4 600 Bruker DMX600 MET 1 n 1 MET 1 A LEU 2 n 2 LEU 2 A VAL 3 n 3 VAL 3 A ALA 4 n 4 ALA 4 A LYS 5 n 5 LYS 5 A SER 6 n 6 SER 6 A SER 7 n 7 SER 7 A ILE 8 n 8 ILE 8 A LEU 9 n 9 LEU 9 A LEU 10 n 10 LEU 10 A ASP 11 n 11 ASP 11 A VAL 12 n 12 VAL 12 A LYS 13 n 13 LYS 13 A PRO 14 n 14 PRO 14 A TRP 15 n 15 TRP 15 A ASP 16 n 16 ASP 16 A ASP 17 n 17 ASP 17 A GLU 18 n 18 GLU 18 A THR 19 n 19 THR 19 A ASP 20 n 20 ASP 20 A MET 21 n 21 MET 21 A ALA 22 n 22 ALA 22 A LYS 23 n 23 LYS 23 A LEU 24 n 24 LEU 24 A GLU 25 n 25 GLU 25 A GLU 26 n 26 GLU 26 A CYS 27 n 27 CYS 27 A VAL 28 n 28 VAL 28 A ARG 29 n 29 ARG 29 A SER 30 n 30 SER 30 A ILE 31 n 31 ILE 31 A GLN 32 n 32 GLN 32 A ALA 33 n 33 ALA 33 A ASP 34 n 34 ASP 34 A GLY 35 n 35 GLY 35 A LEU 36 n 36 LEU 36 A VAL 37 n 37 VAL 37 A TRP 38 n 38 TRP 38 A GLY 39 n 39 GLY 39 A SER 40 n 40 SER 40 A SER 41 n 41 SER 41 A LYS 42 n 42 LYS 42 A LEU 43 n 43 LEU 43 A VAL 44 n 44 VAL 44 A PRO 45 n 45 PRO 45 A VAL 46 n 46 VAL 46 A GLY 47 n 47 GLY 47 A TYR 48 n 48 TYR 48 A GLY 49 n 49 GLY 49 A ILE 50 n 50 ILE 50 A LYS 51 n 51 LYS 51 A LYS 52 n 52 LYS 52 A LEU 53 n 53 LEU 53 A GLN 54 n 54 GLN 54 A ILE 55 n 55 ILE 55 A GLN 56 n 56 GLN 56 A CYS 57 n 57 CYS 57 A VAL 58 n 58 VAL 58 A VAL 59 n 59 VAL 59 A GLU 60 n 60 GLU 60 A ASP 61 n 61 ASP 61 A ASP 62 n 62 ASP 62 A LYS 63 n 63 LYS 63 A VAL 64 n 64 VAL 64 A GLY 65 n 65 GLY 65 A THR 66 n 66 THR 66 A ASP 67 n 67 ASP 67 A MET 68 n 68 MET 68 A LEU 69 n 69 LEU 69 A GLU 70 n 70 GLU 70 A GLU 71 n 71 GLU 71 A GLN 72 n 72 GLN 72 A ILE 73 n 73 ILE 73 A THR 74 n 74 THR 74 A ALA 75 n 75 ALA 75 A PHE 76 n 76 PHE 76 A GLU 77 n 77 GLU 77 A ASP 78 n 78 ASP 78 A TYR 79 n 79 TYR 79 A VAL 80 n 80 VAL 80 A GLN 81 n 81 GLN 81 A SER 82 n 82 SER 82 A MET 83 n 83 MET 83 A ASP 84 n 84 ASP 84 A VAL 85 n 85 VAL 85 A ALA 86 n 86 ALA 86 A ALA 87 n 87 ALA 87 A PHE 88 n 88 PHE 88 A ASN 89 n 89 ASN 89 A LYS 90 n 90 LYS 90 A ILE 91 n 91 ILE 91 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 A A O HG1 GLU THR 70 74 1.49 1 A A O H THR GLU 66 70 1.49 1 A A O H LEU ILE 69 73 1.50 1 A A O H MET GLU 21 25 1.53 1 A A O H LYS CYS 23 27 1.53 1 A A O H LYS GLN 13 81 1.54 2 A A O HE1 ILE TRP 31 38 1.49 2 A A HE1 O TRP GLU 15 77 1.54 2 A A O H LYS CYS 23 27 1.56 2 A A H O SER VAL 6 59 1.56 3 A A HE1 O TRP GLU 15 77 1.49 3 A A O H LEU ILE 69 73 1.51 3 A A H O SER VAL 6 59 1.52 3 A A OE1 H GLU ASP 60 61 1.53 3 A A O H VAL VAL 37 58 1.53 3 A A O H GLU SER 26 30 1.58 4 A A O H MET GLU 21 25 1.50 4 A A O H LEU ILE 69 73 1.50 4 A A O H LYS GLN 13 81 1.54 4 A A O H ASP GLU 67 71 1.56 5 A A O HG1 GLU THR 70 74 1.47 5 A A O H LEU ILE 69 73 1.51 5 A A O H ALA GLU 22 26 1.53 5 A A O H LYS CYS 23 27 1.53 5 A A O H LYS GLN 13 81 1.55 5 A A HE1 O TRP GLU 15 77 1.58 6 A A O H LYS GLN 13 81 1.52 6 A A O H LEU ILE 69 73 1.52 6 A A O H VAL ILE 28 31 1.54 6 A A H O SER VAL 6 59 1.55 7 A A O H LYS GLN 13 81 1.53 7 A A O H LEU ILE 69 73 1.56 7 A A O H LYS CYS 23 27 1.56 7 A A O H GLU SER 26 30 1.57 7 A A H O SER VAL 6 59 1.58 8 A A O H LEU ILE 69 73 1.51 8 A A O H LYS GLN 13 81 1.56 8 A A O H GLU LYS 60 63 1.57 8 A A O H VAL VAL 37 58 1.59 9 A A O H LEU ILE 69 73 1.49 9 A A O H LYS CYS 23 27 1.53 9 A A O H LYS GLN 13 81 1.54 10 A A O H THR GLU 66 70 1.48 10 A A O H LEU ILE 69 73 1.51 10 A A O H MET GLU 21 25 1.55 11 A A H O SER VAL 6 59 1.49 11 A A O H LYS GLN 13 81 1.49 11 A A O H ALA GLU 22 26 1.50 11 A A O H LYS CYS 23 27 1.56 11 A A O H LEU ILE 69 73 1.57 11 A A O HE1 ILE TRP 31 38 1.57 12 A A O HG1 GLU THR 70 74 1.41 12 A A O H LYS GLN 13 81 1.51 12 A A O H LEU ILE 69 73 1.52 12 A A O H LYS CYS 23 27 1.52 12 A A O H GLU SER 26 30 1.59 13 A A O H ALA GLU 22 26 1.48 13 A A O H LEU ILE 69 73 1.49 13 A A O H LYS CYS 23 27 1.50 13 A A HE1 O TRP GLU 15 77 1.51 13 A A O H LYS GLN 13 81 1.51 13 A A H O SER VAL 6 59 1.52 13 A A O H GLU SER 26 30 1.55 14 A A O H LEU ILE 69 73 1.51 14 A A O H LYS CYS 23 27 1.52 14 A A O H THR GLU 66 70 1.53 14 A A O H GLU SER 26 30 1.55 14 A A O H LYS GLN 13 81 1.59 14 A A O H ASP THR 16 19 1.59 14 A A O H VAL LYS 44 52 1.59 15 A A HA H SER ILE 6 91 1.34 15 A A O H LYS GLN 13 81 1.57 15 A A O H LEU ILE 69 73 1.58 16 A A O HG1 GLU THR 70 74 1.46 16 A A O H LYS GLN 13 81 1.50 16 A A HG O SER ASN 6 89 1.54 16 A A O H LYS CYS 23 27 1.59 16 A A O H LEU ILE 69 73 1.60 17 A A O HG1 GLU THR 70 74 1.44 17 A A O H LEU ILE 69 73 1.51 17 A A O H LYS GLN 13 81 1.51 17 A A O H LYS CYS 23 27 1.54 17 A A O H GLU SER 26 30 1.56 18 A A O H THR GLU 66 70 1.48 18 A A O H LYS GLN 13 81 1.53 18 A A O H LEU ILE 69 73 1.54 18 A A O H VAL LYS 44 52 1.56 19 A A O HG1 GLU THR 70 74 1.41 19 A A O H LEU ILE 69 73 1.50 19 A A O H THR GLU 66 70 1.51 19 A A OD1 H ASP GLU 16 18 1.52 19 A A O H LEU ALA 9 86 1.56 19 A A O H ASP GLU 67 71 1.56 20 A A O HG1 GLU THR 70 74 1.43 20 A A O H LYS CYS 23 27 1.49 20 A A O H GLU SER 26 30 1.49 20 A A O H LEU ILE 69 73 1.51 20 A A O H THR GLU 66 70 1.53 20 A A O H LYS GLN 13 81 1.56 1 A LEU 2 -48.96 -83.18 1 A ALA 4 38.99 61.71 1 A THR 19 -52.74 102.54 1 A ASP 20 -53.17 102.24 1 A TYR 48 57.49 164.84 1 A LEU 53 -102.45 66.91 1 A ASP 61 62.77 -79.61 1 A ASP 62 -142.07 26.67 1 A TYR 79 -151.19 -45.48 1 A SER 82 -178.69 112.97 1 A ALA 87 171.86 173.62 2 A LEU 2 -107.61 75.64 2 A ALA 4 70.10 83.37 2 A ASP 11 -150.12 89.32 2 A ASP 16 168.09 -174.28 2 A THR 19 -67.23 88.22 2 A VAL 46 -111.62 -74.28 2 A TYR 48 53.50 -161.55 2 A THR 66 -162.90 27.54 2 A TYR 79 -151.80 -44.03 2 A SER 82 -179.93 115.65 2 A ALA 87 176.01 167.78 3 A ALA 4 84.50 123.24 3 A ASP 16 -175.16 -171.85 3 A THR 19 -50.56 101.21 3 A ASP 20 -52.74 96.94 3 A LEU 53 -103.28 71.44 3 A TYR 79 -147.71 -44.91 3 A SER 82 173.43 114.46 3 A ALA 87 177.51 171.69 4 A ALA 4 76.06 111.12 4 A ASP 16 -174.88 -170.61 4 A THR 19 -60.75 98.27 4 A ASP 20 -40.70 104.32 4 A SER 40 -170.80 141.96 4 A VAL 46 -91.18 -62.17 4 A TYR 48 171.10 -38.22 4 A ASP 62 -146.51 26.08 4 A LYS 63 -96.05 -70.04 4 A ALA 75 -39.53 -31.99 4 A TYR 79 -145.84 -44.10 4 A SER 82 170.09 115.27 4 A ALA 87 179.84 170.41 5 A ALA 4 80.80 84.24 5 A ASP 16 178.64 -174.39 5 A ASP 20 -44.90 154.82 5 A ALA 22 -60.35 -70.64 5 A VAL 46 -90.41 -155.89 5 A TYR 48 175.94 -33.84 5 A LEU 53 -115.69 68.45 5 A ASP 61 53.75 -89.76 5 A ASP 62 -151.91 24.44 5 A THR 66 -76.41 47.57 5 A ASP 67 -96.28 -64.36 5 A TYR 79 -153.73 -44.06 5 A SER 82 179.98 118.65 5 A ALA 87 171.57 176.79 6 A ALA 4 77.49 78.14 6 A ASP 16 179.71 176.72 6 A THR 19 -47.68 106.65 6 A ASP 20 -51.41 95.27 6 A VAL 28 -44.75 -73.50 6 A SER 40 170.00 133.33 6 A VAL 46 -96.41 -71.35 6 A TYR 48 -171.60 82.26 6 A VAL 58 -150.03 68.77 6 A ASP 62 -155.96 25.42 6 A LYS 63 -125.05 -77.38 6 A TYR 79 -148.69 -44.55 6 A SER 82 179.35 106.59 6 A ALA 87 175.58 162.93 7 A LEU 2 -163.30 111.67 7 A ALA 4 56.13 82.74 7 A THR 19 -42.81 98.92 7 A ASP 20 -47.83 95.01 7 A TYR 48 49.79 -90.21 7 A ASP 61 58.96 -83.48 7 A ASP 62 -142.75 25.82 7 A TYR 79 -149.09 -43.75 7 A SER 82 -179.49 112.62 7 A ALA 87 167.60 169.93 8 A ALA 4 79.90 90.90 8 A ASP 16 177.51 -178.40 8 A VAL 46 -148.48 44.08 8 A TYR 48 -38.29 96.60 8 A LEU 53 -101.40 64.58 8 A ASP 61 47.44 -92.08 8 A ASP 62 -146.47 24.44 8 A TYR 79 -150.31 -44.72 8 A SER 82 177.74 107.00 8 A ALA 87 167.08 175.95 9 A LEU 2 -99.27 -154.70 9 A ALA 4 39.06 41.09 9 A THR 19 -38.40 114.23 9 A ASP 20 -59.02 100.54 9 A ALA 33 -169.51 62.34 9 A ASP 34 40.87 -90.24 9 A TRP 38 -106.73 79.66 9 A SER 40 161.88 129.27 9 A LEU 53 -100.46 72.68 9 A ASP 62 -155.06 24.59 9 A LYS 63 -126.38 -78.60 9 A THR 66 -164.63 -40.79 9 A TYR 79 -154.68 -43.13 9 A SER 82 163.45 117.53 9 A ALA 87 173.64 145.27 10 A ALA 4 64.76 98.88 10 A ASP 16 174.41 -172.98 10 A THR 19 -46.60 108.46 10 A ASP 20 -55.27 92.29 10 A LEU 53 -109.45 74.88 10 A ASP 61 59.31 -85.62 10 A TYR 79 -142.05 -42.85 10 A SER 82 171.16 103.52 10 A ALA 87 173.95 176.27 11 A LEU 2 63.33 99.20 11 A ALA 4 72.58 80.13 11 A THR 19 -59.97 104.10 11 A ILE 31 -39.97 123.62 11 A TYR 48 37.98 86.71 11 A VAL 58 -119.92 76.12 11 A ASP 62 -141.62 24.78 11 A LYS 63 -131.88 -77.23 11 A TYR 79 -144.19 -44.50 11 A SER 82 173.68 118.81 11 A ALA 87 168.24 161.34 12 A LEU 2 70.06 44.90 12 A ALA 4 63.64 96.30 12 A ASP 16 174.30 175.80 12 A THR 19 -56.38 96.43 12 A TYR 48 -155.77 87.66 12 A LEU 53 -116.05 61.74 12 A TYR 79 -154.68 -43.85 12 A SER 82 174.56 111.78 13 A LEU 2 -163.30 50.66 13 A ALA 4 89.20 78.30 13 A ASP 16 166.49 -171.11 13 A THR 19 -62.44 97.83 13 A ASP 20 -41.75 154.82 13 A ILE 31 -39.49 122.11 13 A SER 40 -176.67 131.07 13 A VAL 46 -135.80 -47.43 13 A LEU 53 -105.37 60.56 13 A ASP 67 -112.82 -71.06 13 A TYR 79 -154.99 -44.14 13 A SER 82 172.18 112.78 13 A ALA 87 -175.71 149.51 14 A ALA 4 38.54 53.02 14 A ASP 16 177.30 166.81 14 A THR 19 -57.58 102.80 14 A ASP 20 -48.33 102.93 14 A VAL 46 -148.61 58.66 14 A TYR 48 -37.22 106.28 14 A LEU 53 -114.08 75.36 14 A ASP 61 57.70 -86.91 14 A ILE 73 -56.72 -83.25 14 A TYR 79 -155.44 -42.03 14 A SER 82 167.30 119.89 15 A ALA 4 83.52 90.68 15 A ASP 16 167.34 170.94 15 A THR 19 -43.92 102.59 15 A ASP 20 -49.69 105.24 15 A SER 40 160.98 135.53 15 A ASP 62 -155.88 25.20 15 A LYS 63 -125.73 -76.51 15 A ASP 67 -44.12 -72.72 15 A ALA 75 -39.44 -30.33 15 A TYR 79 -151.77 -41.56 15 A SER 82 169.61 112.91 15 A ALA 87 -178.25 -177.57 16 A ALA 4 72.90 86.77 16 A ASP 16 173.63 -176.49 16 A ALA 33 -171.95 147.67 16 A SER 40 174.72 148.32 16 A VAL 46 -84.48 -85.58 16 A TYR 48 -77.19 -157.35 16 A LEU 53 -100.63 75.46 16 A VAL 58 -153.50 73.43 16 A ASP 62 -151.69 25.83 16 A LYS 63 -113.15 -89.67 16 A THR 66 -170.86 -40.15 16 A TYR 79 -145.31 -44.02 16 A SER 82 -179.85 128.46 16 A ALA 87 164.90 161.10 17 A THR 19 -56.63 99.45 17 A ILE 31 -39.96 127.08 17 A TYR 48 175.25 -34.03 17 A LEU 53 -112.95 73.74 17 A VAL 58 -151.23 78.80 17 A ASP 62 -160.42 26.30 17 A LYS 63 -132.33 -64.42 17 A THR 66 35.09 42.06 17 A ASP 67 -101.03 -60.01 17 A PHE 76 -111.51 79.18 17 A TYR 79 -155.03 -43.80 17 A SER 82 172.89 112.42 17 A PHE 88 -153.89 88.26 18 A ALA 4 88.65 77.43 18 A ASP 16 -178.47 -176.50 18 A ASP 20 -52.88 95.02 18 A LEU 53 -102.74 68.63 18 A CYS 57 -116.63 -166.97 18 A VAL 58 -151.39 59.82 18 A ASP 62 -144.55 25.55 18 A LYS 63 -131.58 -92.46 18 A ASP 67 -39.18 -77.32 18 A TYR 79 -147.62 -41.50 18 A SER 82 168.57 113.41 18 A ALA 87 -176.29 145.54 18 A PHE 88 -155.46 85.73 19 A LEU 2 -44.93 109.05 19 A ALA 4 84.12 83.32 19 A ASP 16 163.09 166.81 19 A THR 19 -39.98 101.68 19 A ASP 20 -51.24 99.35 19 A VAL 46 -106.35 -70.14 19 A TYR 48 68.61 -63.24 19 A VAL 58 -108.83 77.01 19 A ASP 62 -91.02 -67.62 19 A ASP 67 -44.16 -72.86 19 A TYR 79 -149.34 -43.87 19 A SER 82 -176.97 131.69 19 A PHE 88 -152.68 89.47 20 A LEU 2 58.07 98.89 20 A ALA 4 75.64 80.66 20 A THR 19 -49.93 95.50 20 A TYR 48 68.73 -64.71 20 A LEU 53 -108.63 69.61 20 A ASP 61 68.28 -68.12 20 A ASP 62 -155.13 27.64 20 A TYR 79 -153.20 -44.63 20 A SER 82 174.46 115.49 20 A ALA 87 170.77 173.37 model building DYANA refinement DYANA SOLUTION STRUCTURE OF THE GUANINE NUCLEOTIDE EXCHANGE FACTOR DOMAIN FROM HUMAN ELONGATION FACTOR-ONE BETA, NMR, 20 STRUCTURES 1 Y N A ALA 22 A ALA 22 HELX_P A SER 30 A SER 30 1 H1 9 A THR 66 A THR 66 HELX_P A THR 74 A THR 74 1 H2 9 GUANINE NUCLEOTIDE EXCHANGE FACTOR GUANINE NUCLEOTIDE EXCHANGE FACTOR, G-PROTEIN, TRANSLATION ELONGATION EF1B_HUMAN UNP 1 1 P24534 GFGDLKSPAGLQVLNDYLADKSYIEGYVPSQADVAVFEAVSSPPPADLCHALRWYNHIKSYEKEKASLPGVKKALGKYGP ADVEDTTGSGATDSKDDDDIDLFGSDDEEESEEAKRLREERLAQYESKKAKKPALVAKSSILLDVKPWDDETDMAKLEEC VRSIQADGLVWGSSKLVPVGYGIKKLQIQCVVEDDKVGTDMLEEQITAFEDYVQSMDVAAFNKI 135 224 1B64 2 91 P24534 A 1 2 91 4 anti-parallel anti-parallel anti-parallel A VAL 37 A VAL 37 A PRO 45 A PRO 45 A ILE 50 A ILE 50 A GLN 56 A GLN 56 A LYS 5 A LYS 5 A PRO 14 A PRO 14 A VAL 80 A VAL 80 A LYS 90 A LYS 90 INVOLVED WITH GEF REACTION ON EF-1APHA. Unknown 1 A TYR 48 A TYR 48 1 1_555 1 P 1